Carson Wealth (CWM LLC)
TRDA icon

Carson Wealth (CWM LLC)’s Entrada Therapeutics TRDA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.7K Buy
6,788
+4,674
+221% +$53.6K ﹤0.01% 3399
2025
Q4 		$22K Buy
2,114
+921
+77% +$7.76K ﹤0.01% 4129
2025
Q3 		$7K Buy
1,193
+816
+216% +$4.77K ﹤0.01% 4642
2025
Q2 		$3K Buy
377
+216
+134% +$1.74K ﹤0.01% 4817
2025
Q1 		$1K Sell
161
-309
-66% -$3.85K ﹤0.01% 4996
2024
Q4 		$8K Buy
470
+320
+213% +$5.8K ﹤0.01% 4016
2024
Q3 		$2K Buy
150
+133
+782% +$2.1K ﹤0.01% 4465
2024
Q2 		$0 Buy
17
+16
+1,600% +$227 ﹤0.01% 4945
2024
Q1 		$0 Buy
+1
New +$14 ﹤0.01% 4748

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TRDA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Entrada Therapeutics (TRDA) stake by 221% in Q1 2026, buying an estimated $53.6K and bringing the position to 6,788 shares worth $85.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Carson Wealth (CWM LLC) first reported a position in TRDA in Q1 2024 and has held it in 9 quarters since. 120 funds tracked by Wall St. Rank hold TRDA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,788 shares of Entrada Therapeutics worth $85.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 4,674 Entrada Therapeutics shares in Q1 2026, an estimated $53.6K.
  • Entrada Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3399 holding.
  • Carson Wealth (CWM LLC) first reported a position in Entrada Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 120 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.